Figure 2: Possible divergent clonal trajectories of the JAK2 V617F-positive myeloproliferative neoplasm and acute myeloid leukemia in tandem with normal hematopoiesis. AML: acute myeloid leukemia; MPN: myeloproliferative neoplasm; HSC: hematopoietic stem cell.